期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Liver Cirrhosis and Intestinal Bacterial Translocation 被引量:3
1
作者 Tao Lan Bao-chun Chen +3 位作者 Li-ping Fu Zhi-juan Li xiang-jun wu Nai-qiang Cui 《国际感染病学(电子版)》 CAS 2014年第3期133-138,共6页
Intestinal barrier dysfunction, facilitating translocation of bacteria and bacterial products, plays an important role in the pathophysiology of liver cirrhosis and its complications. Intestinal defense system includi... Intestinal barrier dysfunction, facilitating translocation of bacteria and bacterial products, plays an important role in the pathophysiology of liver cirrhosis and its complications. Intestinal defense system including microbial barrier, immunologic barrier, mechanical barrier, chemical barrier, plays an important role in the maintenance of intestinal function. Under normal circumstances, the intestinal barrier can prevent intestinal bacteria through the intestinal wall from spreading to the body. Severe infection, trauma, shock, cirrhosis, malnutrition, immune suppression conditions, intestinal bacteria and endotoxin translocation, can lead to multiple organ dysfunction. The intestinal microflora is not only involved in the digestion of nutrients, but also in local immunity, forming a barrier against pathogenic microorganisms. The derangement of the gut microflora may lead to microbial translocation, defined as the passage of viable microorganisms or bacterial products from the intestinal lumen to the mesenteric lymph nodes and other extraintestinal sites. In patients with cirrhosis, primary and intestinal flora imbalance, intestinal bacterial overgrowth, intestinal mucosal barrier dysfunction, endotoxemia is associated with weakened immunity. 展开更多
关键词 CIRRHOSIS Intestinal barrier Bacterial translocation ENDOTOXEMIA
暂未订购
补骨脂及其经典方剂的谱-毒关系研究
2
作者 师卓 潘锦超 +8 位作者 张程 崔嘉露 吴香军 李方扬 李茂星 肖成荣 马增春 王宇光 高月 《Acupuncture and Herbal Medicine》 2024年第2期234-242,I0011,共10页
补骨脂是临床常用的补益类中药,近年来补骨脂相关制剂不良反应事件频发,如何保障其临床合理用药是领域内的难点问题。本文以尚无不良反应报道、安全性较高的二神丸、四神丸经典类方与补骨脂进行毒性的比较研究,从整体水平评价补骨脂、... 补骨脂是临床常用的补益类中药,近年来补骨脂相关制剂不良反应事件频发,如何保障其临床合理用药是领域内的难点问题。本文以尚无不良反应报道、安全性较高的二神丸、四神丸经典类方与补骨脂进行毒性的比较研究,从整体水平评价补骨脂、二神丸、四神丸的急性毒性作用,测定补骨脂的LD50值为53.9 g/kg。二神丸LD50值为68.3 g/kg,具有配伍减毒作用。四神丸无法测定LD50值,MTD值为41.0 g/kg,配伍减毒效果更显著。进一步通过谱-毒相关分析发现补骨脂中13个化合物在二神丸、四神丸配伍后显著降低,初步提示了二神丸、四神丸配伍减毒的物质基础,为后续配伍减毒机理研究提供科学参考。 展开更多
关键词 二神丸 肝损伤 补骨脂 四神丸 毒理学
暂未订购
Novel non-synonymous mutations of PAX8 in a cohort of Chinese with congenital hypothyroidism 被引量:2
3
作者 Fang Qian Gui-Yu Li +4 位作者 xiang-jun wu Qin Jia Guan-Ting Lyu Man-Li Wang Jun Wang 《Chinese Medical Journal》 SCIE CAS CSCD 2019年第11期1322-1327,共6页
Background:The transcription factor paired box 8(PAX8)was associated with type 2 congenital non-goitrous hypothyroidism(CHNG2),a clinical phenotype of congenital hypothyroidism(CH).Though studied in a few regions with... Background:The transcription factor paired box 8(PAX8)was associated with type 2 congenital non-goitrous hypothyroidism(CHNG2),a clinical phenotype of congenital hypothyroidism(CH).Though studied in a few regions with different ethnicities,the incidence of PAX8 mutations varied,even among Chinese cohorts in different regions.This study aimed to identify and characterize PAX8 mutations and explore the prevalence of its mutations in another cohort of CH.Methods:The 105 unrelated Chinese patients with CH were collected from four major hospitals.Exomes of the 105 samples were sequenced by Hiseq 2000 platform to identify mutations of PAX8 on genomic DNAs extracted from peripheral blood samples.Luciferase reporter assays were used to assess the effects of mutations on the transcription of thyroid peroxidase(TPO).Results:Three PAX8 mutations in four subjects were identified in 105 samples.One variant,rsl 89229644,was detected in two subjects,and categorized as uncertain significance.The other two missense mutations(275T>C/Ile92Thr and 398G>A/Argl33Gln)were not detected in three large-scale genotyping projects,namely 1000 Genome Project,Exome Aggregation Consortium and GO Exome Sequencing Project.Functional studies for the two mutations revealed that they could impair the transcription ability of PAX8 on one of its target genes,TPO.Therefore,the two mutations were causative for the pathogenesis of CHNG2.After combining the studies of PAX8 mutations,an average frequency of 1.74%(21/1209)could be obtained in Chinese patients with CH.Conclusion:The study specifically demonstrates the role of two mutations in impairing the transcription ability of PAX8,which should be considered as pathogenic variants for CH. 展开更多
关键词 Congenital hypothyroidism Paired box 8 Novel non-synonymous mutation Transcription factor
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部